KRAS and colorectal carcinoma: The analyses revealed that the SNP LCS6 T>G in this region is associated with improved survival in patients with early-stage CRC; therefore, the G allele in KRAS-LCS6 can be considered a promising prognostic biomarker for early-stage CRC [38].